Avid Bioservices Inc (CDMO)

[biopharm]

Bird & Bird advises Precision Medicine Group on the acquisition of Epiontis
09 October 2017

Bird & Bird LLP advises Precision Medicine Group, a scientific services company helping life science innovators develop medical products, on the acquisition of all shares in Epiontis GmbH, a leading immune monitoring and epigenetic technology service provider based in Berlin.

The acquisition will allow Precision for Medicine to expand on its immune monitoring capabilities with Epiontis’s epigenetic technology, and strengthen its global footprint in the rapidly expanding precision medicine sector.

The Bird & Bird team advised Precision for Medicine on the due diligence, signing and closing of the transaction, including IP patent due diligence and regulatory advice regarding the life sciences aspects of the deal.

Stefan Münch (Corporate/M&A, Munich) led the transaction on the German law aspects, assisted by counsel Stephan Kübler and associates Michael Gassner and Benedikt Weiss (both Corporate/M&A, Munich), partner Ralph Panzer and associate Julia Gottinger (both Employment, Munich), counsel Gerrit Wiedow (Employment, Hamburg), partners Michael Alt, Christopher Maierhöfer and associate Marie-Theres Schmid (all Patents, Munich), partner Markus Körner and counsel Thomas Urband (both Trademarks, Munich), partner Alexander Csaki and associate Clarissa Junge-Gierse (both Life Sciences/Regulatory, Munich) and partner Michael Jünemann (Finance, Frankfurt). Bird & Bird London partner Ali Ramadan and associate Hannah Fletcher (both Corporate/M&A, London) also assisted on the UK law issues. Legal in-house advisors were General Counsel John Mariano and Senior Counsel Rita Khoobchandani.

https://www.twobirds.com/en/news/press-releases/2017/germany/bird-and-bird-advises-precision-medicine-group-on-the-acquisition-of-epiontis

So in the midst of collaborations and data to be released Nov 8 2017....Precision for Medicine all of a sudden advised to buy out Epiontis (where Ivana Turbachova suddenly passed away....) and did she want to sell out ?? ....very strange as we see Nov 8 just a week or so away....and can Bird/Bird advise to buy out a company based upon PS Targeting collaborations data and/or based on undisclosed info..........hmmmm.

-----

P18 and P35 also withdrawn and P87 below .....with Precision for Medicine that buys out Epiontis

SITC 2017 Abstract Titles – Biomarkers and Immune Monitoring - SITC 2017 - Society for Immunotherapy of Cancer
https://www.sitcancer.org
1Peregrine Pharmaceuticals, Tustin, CA, USA 2Epiontis GmbH, Berlin, Germany 3Precision Medicine ...

P87
Results of epigenetic-based quantitative PCR assisted immune cell counting analysis in bavituximab SUNRISE trial subgroup

Nikoletta L. Kallinteris1, Thomas O. Kleen2, Min Tang1, Shen Yin1, Tobi Guennel3, Jennifer Lai1, Victor Nowakowski2, Steven Olek2, Steve King1, Joseph S. Shan1

1Peregrine Pharmaceuticals, Tustin, CA, USA

2Epiontis GmbH, Berlin, Germany

3Precision Medicine, Frederick, MD, USA
Biomarkers | Clinical trial | Antibody | Monocyte/Macrophage | MDSC | Checkpoint blockade | Immune suppression | T cell | NK/NK T cell | Regulatory T cell (Treg)
P88

https://www.sitcancer.org/2017/abstracts/titles/biomarkers-immune-monitoring